Toshinori Murayama

Kanazawa University Hospital — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

41h-index7.7kcitations146works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Angiogenesis and VEGF in Cancer(27), Atherosclerosis and Cardiovascular Diseases(20), Adipokines, Inflammation, and Metabolic Diseases(16), Ethics in Clinical Research(8), Cancer, Hypoxia, and Metabolism(8)

Publications145 total

Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer
Annals of Nuclear Medicine·2024· 2 citedOpen Access
Research on education and training for researchers and supporters on the concept of Quality Management System (QMS) in Japan.
2024
A clinical assessment of portable point-of-care testing for quick cortisol assay during adrenal vein sampling
Scientific Reports·2023· 3 citedOpen Access
Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study
Frontiers in Oncology·2022· 11 citedOpen Access
Randomized, placebo-controlled, double blind, phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors.
Journal of Clinical Oncology·2022
Compensation for Bodily Health Damage Related to Clinical Research, and Clinical Research Insurance in Japan
2022
A use-case analysis of Clinical Data Interchange Standards Consortium/Study Data Tabulation Model in academia in an investigator-initiated clinical trial.
PubMed·2022· 6 citedOpen Access
Author Correction: A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
Scientific Reports·2022· 1 citedOpen Access
Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation
European Journal of Nuclear Medicine and Molecular Imaging·2021· 5 cited
Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature Review
Internal Medicine·2021· 4 citedOpen Access
Clinical trial of autologous adipose tissue-derived regenerative (stem) cells therapy for exploration of its safety and efficacy
Regenerative Therapy·2021· 25 citedOpen Access
The status of central ethical reviewing and challenges regarding its introduction to non-interventional studies in Japan.
PubMed·2021Open Access
Serum Laminin γ2 Monomer as a Diagnostic and Predictive Biomarker for Hepatocellular Carcinoma
Hepatology·2021· 44 cited
Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)
Translational Lung Cancer Research·2021· 31 citedOpen Access
Study protocol for daiobotanpito combined with antibiotic therapy for treatment of acute diverticulitis: a study protocol for a randomized controlled trial
Trials·2020· 4 citedOpen Access
Feasibility of a Novel Mobile C-Reactive Protein–Testing Device Using Gold-Linked Electrochemical Immunoassay: Clinical Performance Study
JMIR mhealth and uhealth·2020· 6 citedOpen Access
Non-interventional research guidelines and infrastructure development of central ethics review board in Japan
2020
Study Protocol Daiobotanpito combined with antibiotic therapy for treatment of acute diverticulitis: a study protocol for a randomized controlled trial
Research Square (Research Square)·2020Open Access
Feasibility of a Novel Mobile C-Reactive Protein–Testing Device Using Gold-Linked Electrochemical Immunoassay: Clinical Performance Study (Preprint)
2020Open Access
Regenerative Therapy for Liver Cirrhosis Based on Intrahepatic Arterial Infusion of Autologous Subcutaneous Adipose Tissue-Derived Regenerative (Stem) Cells: Protocol for a Confirmatory Multicenter Uncontrolled Clinical Trial
JMIR Research Protocols·2020· 10 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Masayuki Yokode(28), Toru Kita(14), Marcy Silver(13), Douglas W. Losordo(13), Hidenori Arai(10), Takayuki Asahara(9), Hideto Sano(8), Satoshi Teramukai(8), Marianne Kearney(7), Manabu Minami(6), Akira Shimizu(6), Hiroyuki Ariyasu(6), Takashi Akamizu(6), Rudolf Kirchmair(5), Jeffrey M. Isner(5), Allison Hanley(5), Cynthia J. Curry(5), Kenichi Yoshimura(5), Tina Thorne(4), Atsuhiko Kawamoto(4)